Research Focus: IDKmonitor® Adalimumab ELISAs
Immundiagnostik’s IDKmonitor® Adalimumab ELISAs were featured in a study aimed to explore the relationship between adalimumab drug levels and biologic remission for Crohn’s disease.
Category: Company News
Discover the latest news and updates from Immundiagnostik, Inc.
7 Ways to Help Monitor Adherence to a Gluten-Free Diet
There are many ways to help monitor adherence to a gluten-free diet and identify unintentional consumption. Read our blog to discover what each can offer.
New Immundiagnostik Test Simplifies Detecting, Measuring Unintentional Gluten Consumption
Labcorp (NYSE: LH), a leading global life sciences company, is the first U.S. commercial laboratory to offer a new test developed by Immundiagnostik, Inc. to help individuals detect and quantify unintentional gluten consumption.
Research Focus: Calprotectin Mouse/Rat ELISA (S100A8/A9, MRP 8/14)
A study aimed to investigate the connection between serum levels of vitamin D, folate, and cobalamin and IBD-related biomarkers using the IDK Extract®.
Research Focus: IDK® anti-SARS-CoV-2 IgG ELISA
Immundiagnostik’s IDK® anti-SARS-CoV-2 IgG ELISA was recently featured in a publication. Read our post to see how the assay compared to others on the market.
eBook: The Connection Between Vitamin D and IBD
Download our ebook to explore the impact of vitamin D deficiency in irritable bowel diseases and learn more about the connection between vitamin D and IBD.
Low Vitamin D Linked to Higher COVID-19 Risk
Recently, several studies have associated low vitamin D levels with a higher risk of contracting COVID-19. Read our blog to learn more about the research.
How Circulating Calprotectin Can Predict COVID-19 Severity
Read our blog post to review recent research that demonstrates how circulating calprotectin can predict COVID-19 severity.